Financial Health Assessment: RAMORE HOLDINGS LTD

1. Financial Health Score: B+

Explanation: The patient exhibits robust vitality in terms of asset growth and liquidity, but carries a significant long-term debt condition that requires monitoring. The steady improvement in net worth suggests a recovering and strengthening constitution, though the limited disclosure as a micro-entity means some vital diagnostic information remains obscured—like reading an X-ray with several dark spots.

2. Key Vital Signs

Heart Rate: Asset Growth

Interpretation: The company experienced a dramatic expansion around 2020-2021, with total assets growing from £316k to over £2.3M—a roughly 7x increase. This coincided with the assumption of significant long-term debt. Net asset growth has been consistently positive since 2021, though the pace is decelerating (from 115.7% to 8.2%), which is natural as the base grows larger. The "heartbeat" is strong but normalising.

Blood Pressure: Liquidity Ratio

Interpretation: An exceptionally healthy current ratio of nearly 10:1. The company has ample liquid resources to meet short-term obligations—this is like having excellent blood pressure with no risk of stroke from cash flow crises. However, a ratio this high may also indicate under-utilised assets that could be deployed more productively.

Cholesterol: Leverage Assessment

Interpretation: The debt-to-asset ratio of 63.6% is moderately elevated—like borderline cholesterol levels. The critical concern is that the long-term debt of £1,546,470 has remained completely static since at least 2020, suggesting this may be a related-party loan or a mortgage-style arrangement with no active repayment. This debt represents 64% of total assets and has been a constant presence for four consecutive years.

Body Temperature: Operational Warmth

Interpretation: With only £183 in fixed assets and 2 employees, this is not a "warm-bodied" operating company in the traditional sense. The name change to "RAMORE HOLDINGS" in 2017 and the asset profile strongly suggest this is a holding or investment vehicle rather than an active manufacturer—despite the SIC code indicating "Other manufacturing." The negligible fixed assets (down 50% year-over-year) confirm the company holds primarily financial assets, not production capacity.

3. Diagnosis

Primary Condition: Healthy but heavily leveraged holding company with limited disclosure transparency

The financial data reveals a company that underwent a significant transformation around 2019-2020, acquiring substantial assets (likely investment properties or financial instruments) financed primarily through long-term debt. The patient's "vital organs" are functioning—net assets are growing, liquidity is excellent, and there are no signs of immediate distress.

Key Diagnostic Findings:

1. Asset Composition Mystery: The company holds £2.4M in assets but only £183 in fixed assets. The balance is almost entirely in current assets, which for a holding company typically means investment holdings, loans to subsidiaries, or cash deposits. Without fuller accounts, the exact nature remains unclear.

2. Static Long-term Debt: The £1,546,470 in long-term creditors has been identical for four years. This is unusual and raises questions: - Is this a related-party loan from the Hemphill family or associates? - Are there repayment terms, or is it perpetual? - Is interest being charged, and if so, is it being paid or capitalised?

3. Declining Profitability Momentum: While net assets grew by £48,132 in 2024 (8.2%), this is a significant deceleration from the £315,760 growth in 2023. This could indicate diminishing returns on the asset base or increasing costs not visible in micro-entity accounts.

4. Micro-Entity Limitations: As a micro-entity, the company files abbreviated accounts with no profit & loss statement, no cash flow statement, and minimal notes. This is like a patient who only allows you to check their pulse—important, but insufficient for a complete health picture.

Risk Factors: - The long-term debt is a significant structural concern if terms are unfavourable or if asset values decline - The SIC code (manufacturing) appears inconsistent with the actual business model - Concentration of control in two PSCs (Hemphill and Cobb families) means decisions rest with very few individuals - The company's previous name change (from ROSC & CO LIMITED) suggests a strategic pivot that may have introduced the current debt structure

Positive Indicators: - Consistent net asset growth over multiple years - No overdue filings with Companies House - Strong liquidity position - Active, compliant status - The gap between total assets and total liabilities is widening (improving equity position)

4. Prognosis

Short-term (1-2 years): Favourable. The company's strong liquidity and growing equity base suggest it can meet its obligations and continue building value. The lack of immediate creditor pressure (current liabilities are only 10% of current assets) provides a comfortable buffer.

Medium-term (3-5 years): Cautiously optimistic, dependent on debt resolution. The static long-term debt must eventually be addressed. If asset values are maintained or grow, and the debt terms are favourable (low/no interest, long maturity), the prognosis remains positive. However, if the debt carries significant interest or has a near-term maturity, this could become acute.

Long-term: Stable with monitoring required. The holding company structure appears sustainable, but the ultimate health depends on the performance of underlying investments/assets that are not disclosed in micro-entity accounts.

5. Recommendations

Immediate Actions (Prescription for Today)

1. Debt Diagnosis: Obtain clarity on the £1,546,470 long-term debt. Request information on: - Maturity date and repayment schedule - Interest rate and terms - Whether this is a related-party transaction - Any security or charges against assets

2. Asset Composition Review: Understand what comprises the £2.4M in current assets. Are these: - Loans to group companies? - Investment properties held for sale? - Financial instruments? - Cash and deposits?

This is essential for understanding the true risk profile—£2.4M in illiquid receivables carries very different risk than £2.4M in listed securities.

Medium-term Actions (Treatment Plan)

3. Consider Voluntary Enhanced Disclosure: While micro-entity status minimises filing requirements, providing fuller accounts would: - Improve transparency for stakeholders - Demonstrate financial stewardship - Assist if seeking external finance or partnerships

4. Debt Reduction Strategy: Develop a plan to reduce the long-term debt. Even modest annual repayments would: - Improve the debt-to-equity ratio - Reduce interest costs (if applicable) - Strengthen the balance sheet

5. SIC Code Review: The current classification (32990 - Other manufacturing) appears inconsistent with a holding company structure. Consider whether this should be updated to reflect actual activities (e.g., 64209 - Activities of other holding companies).

Ongoing Health Maintenance

6. Annual Health Check: Monitor these key metrics annually: - Net asset growth rate (currently 8.2%—watch for further deceleration) - Current ratio maintenance (target: stay above 3:1) - Long-term debt reduction progress - Asset quality and liquidity

7. Stress Testing: Model scenarios where: - Asset values decline by 10-20% (what happens to equity and debt covenants?) - Interest rates increase on long-term debt - Key counterparties or investees experience distress